ELEVIDYS
LIVE

Serial Number

88886693

Owner

SAREPTA THERAPEUTICS, INC.

Attorney

Maury M. Tepper, III

First Use Date

Mar 11, 2023

Filing Date

Apr 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ELEVIDYS Trademark

Serial Number: 88886693 • Registration: 7037471

ELEVIDYS is a trademark filed by SAREPTA THERAPEUTICS, INC. on April 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SAREPTA THERAPEUTICS, INC. (109 trademarks)

215 FIRST STREET, SUITE 7
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

April 24, 2020

Registration Date

April 25, 2023

First Use Anywhere

March 11, 2023

First Use in Commerce

March 11, 2023

Published for Opposition

July 14, 2020

Goods & Services

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 25, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 23, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 22, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 20, 2023 SUPC
USE AMENDMENT FILED
Mar 14, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 14, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 6, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2023 AITU
SOU EXTENSION 5 FILED
Feb 17, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 24, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 24, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 24, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 17, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 17, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 17, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 26, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 26, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 26, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 19, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 19, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 19, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 8, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2020 CNSA
ASSIGNED TO EXAMINER
Jun 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2020 NWOS
NEW APPLICATION ENTERED
Apr 28, 2020 NWAP